0GZV.LSE Getinge AB ser. B

Healthcare Commercial Services & Supplies London Exchange
228.03 SEK
Close of Nov 3, 2026
172.07 280.10
Market cap
SEK 62.1B
P/E
21.7x
P/B
-
ROE
-
Dividend yield
0.02%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2023.

Is 0GZV.LSE undervalued?

Graham number

The Graham number of Getinge AB ser. B cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Getinge AB ser. B fundamental analysis

No fundamental analysis for Getinge AB ser. B yet.

Getinge AB ser. B stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Getinge AB ser. B

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company provides surgical perfusion, endoscopic vessel h…

Full company profile